Different antihyperglycaemic drug effects on glycaemic variability in Type 2 diabetic patients
Optimizing treatments for type 2 diabetes mellitus (T2DM) remains an urgent issue. In addition to T2DM treatment strategies, such as glycaemic goals (glucose and glycated haemoglobin ? HbА1c) among different patient populations, the influence of glycaemic variability (GV) on the prognosis of patient...
Enregistré dans:
Auteurs principaux: | , , , , |
---|---|
Format: | article |
Langue: | EN RU |
Publié: |
Endocrinology Research Centre
2014
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/eff73a7fd76a4619b9da53893fae77f0 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|